Today, members of Rescuing Biomedical Research published an article in Science proposing the expansion of the National Institutes of Health’s New Innovator (DP2) award. The DP2 award is available only to early-stage investigators and places an emphasis on novel scientific ideas without requiring significant preliminary data. The DP2 program has received a positive evaluation, and […]
The biomedical research enterprise strives to be a meritocracy, but structural inequities and the reliance on nonscientific proxies such as journal impact and university prestige present roadblocks. Attempts to alleviate these problems are numerous— for example, ASAPbio, the grant-support index, the National Research Mentoring Network, and the Building Infrastructure Leading to Diversity—and have met with […]
By Kelsey Hampton Intense competition for a limited amount of federal funding has long been a reality for biomedical researchers. In a post on the Open Mike blog, Michael Lauer, deputy director for extramural research at the National Institutes of Health, and his team examined the pool of research project grant applicants to determine what […]
By Adriana Bankston, Ph.D. The ability to make novel scientific discoveries is largely dependent on principal investigators being able to secure federal funding. This is often in the form of an R01 grant from the National Institutes of Health.
Peer review, as conducted by the National Institutes of Health, is not great at determining relative merit among the top 20 to 30 percent of grants. A new paper by Ferric Fang and Arturo Cassadevall expands on their previous proposal to fund meritorious grants by a lottery system rather than continuing to use the rankings […]